BTIG Reiterates Buy on Jade Biosciences, Maintains $77 Price Target
Benzinga Newsdesk 6 days ago
Analyst RatingsNewsReiterationPrice Target
BTIG analyst Julian Harrison reiterates Jade Biosciences (NASDAQ:JBIO) with a Buy and maintains $77 price target.
BTIG analyst Julian Harrison reiterates Jade Biosciences (NASDAQ:JBIO) with a Buy and maintains $77 price target.